CCS
PDLI

Crosspoint Capital Strategies’s PDL BioPharma, Inc. PDLI Stock Holding History

Crosspoint Capital Strategies’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-3,877
Closed -$30K – 1036
2015
Q4 		$30K Buy
+3,877
New +$30K 0.01% 523